Kinvard Bio Inc., a Raleigh, NC-based biotechnology firm offering a brand new class of broad-spectrum antibiotics, obtained US$2.7M follow-on non-dilutive…
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
You can revoke your consent any time using the Revoke consent button.